NovaBay Pharmaceuticals Provides Q1 – 2012 Financial Results

EMERYVILLE, Calif. — NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing novel anti-infective products for the treatment and prevention of microbial infections, …